STOCK TITAN

BlackRock (NASDAQ: VGNT) reports 8,084,933 shares, 11.4% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Versigent plc ownership report: BlackRock, Inc. beneficially owns 8,084,933 shares of Versigent common stock, representing 11.4% of the class. The Schedule 13G lists sole voting power for 7,884,995 shares and sole dispositive power for 8,084,933 shares. The filing also notes that iShares Core S&P Small-Cap ETF holds more than 5% of Versigent common stock.

Positive

  • None.

Negative

  • None.
Filing type Schedule 13G Ownership disclosure for passive investors
Beneficially owned 8,084,933 shares Amount beneficially owned reported in Item 4
Percent of class 11.4% Percent of Versigent common stock reported
Sole voting power 7,884,995 shares Shares with sole power to vote (Item 4(i))
Sole dispositive power 8,084,933 shares Shares with sole power to dispose (Item 4(iii))
Other >5% holder iShares Core S&P Small-Cap ETF Item 6 identifies another person with >5% interest
Schedule 13G regulatory
"Item 1(a) Name of issuer: VERSIGENT PLC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership financial
"Item 4. Amount beneficially owned: 8084933"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole Dispositive Power regulatory
"Item 4(iii) Sole power to dispose or to direct the disposition of: 8084933"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.





G9600F104

(CUSIP Number)
04/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:05/06/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

FAQ

What stake does BlackRock report in Versigent (VGNT)?

BlackRock reports 8,084,933 shares (11.4%) of Versigent common stock. This figure is shown as the amount beneficially owned on the Schedule 13G, with voting and dispositive powers detailed in Item 4 of the filing.

When was the Schedule 13G for VGNT signed and filed by BlackRock?

The signature on the excerpt is dated 05/06/2026. The cover data lists a date of 04/30/2026, and the filing is signed by Spencer Fleming, Managing Director, on the Schedule 13G.

Does the filing show who controls voting or disposition of the VGNT shares?

Yes. The filing shows sole voting power for 7,884,995 shares and sole dispositive power for 8,084,933 shares, with no shared voting or dispositive powers reported in Item 4.

Are there other holders above 5% of Versigent reported in the excerpt?

The excerpt states that iShares Core S&P Small-Cap ETF has an interest exceeding 5% in Versigent common stock, identified under Item 6 as a person on whose behalf shares are held.